Summary
Overview
Work History
Education
Skills
Publications
Volunteer Experience
Timeline
Generic

Shana Ravvin

New York,NY

Summary

7 years of wet lab experience, as well as recent work in assay development (ELISA, FLISA), involving antibody screening/optimization, cell culture (mainly human cancer cell lines), cell-based assays for testing drug efficacy, FFPE tissue staining, and microscopy/image analysis. Strong data collection/research, analysis, and presentation skills. Experience running a lab and managing staff. Proficient in SpectraMax, Varioskan LUX, Biostacker, and chemical/biological hoods.

Overview

6
6
years of professional experience

Work History

Scientist

AVETA.LIFE
01.2023 - Current
  • Design, execute, and optimize enzyme-linked immunosorbent assays (ELISA) to improve quality and accuracy of diagnostic tool using novel linker method.
  • Collect and analyze data for patent and FDA form submission.
  • Research, create, and deliver scientific and non-scientific presentations for senior executives and potential investors to articulate company’s value proposition and explain the science in persuasive layman terms.
  • Contributed to whitepapers and pending publications.

R&D Intern | Scientist

FREZENT BIOLOGICAL SOLUTIONS
06.2022 - 06.2023
  • Supported company’s mission to develop novel peptide inhibitor and antibody-drug conjugates for targeting dormant cancer cells that may cause cancer recurrence.
  • Designed and conducted cell-based assays on cancer and non-cancer cell lines to assess efficacy, safety, and cell permeability of a novel drug.
  • Created protocol to multiplex stain fixed cancer tissue microarrays in humans to identify relationships between 3 proteins related to cancer and drug efficacy.
  • Prepared samples for HPLC to characterize novel drug stability.
  • Presented data and images of stained tissue in weekly meetings to team.

Lab Manager

CITY COLLEGE OF NEW YORK (CCNY) ATHEROSCLEROSIS LAB
02.2018 - 03.2020
  • Provided research support to Professor David Rumschitzki (including main experiment procedure consisting of performing surgery on a rat) in the study of Early Atherogenisis: the effect of pressure and Aquaporin-1 on sub-endothelial intima compression
  • Held oversight of lab operations during PI's one-year sabbatical and oversaw inventory
  • Staff: 8 with 3 direct reports
  • Designated heads to each section in lab (rat surgery, tissue sectioning, tissue staining, tissue imaging, and image analysis) to streamline operations, eliminate bottlenecks, provide transparency on progress, and improve reporting efficiencies during staff meetings
  • Developed system for tracking lab member training to match staff to lab assignments and improve productivity.

Education

MS - Biotechnology

New York University
01.2023

BE - Biomedical Engineering

City College of New York
01.2021

Skills

  • Assay development
  • Research methods
  • Cell Culture Techniques
  • Routine Laboratory Operations
  • Protein Purification
  • Spectroscopy Techniques
  • Team Collaboration
  • Molecular Biology

Publications

Effects of Hormone Replacement Therapy on Women's Lung Health and Disease, NIH National Center for Biotechnology, 12/2023

Volunteer Experience

Mt. Sinai Health System, New York, NY, 01/2023, Present, Research Assistant

Timeline

Scientist

AVETA.LIFE
01.2023 - Current

R&D Intern | Scientist

FREZENT BIOLOGICAL SOLUTIONS
06.2022 - 06.2023

Lab Manager

CITY COLLEGE OF NEW YORK (CCNY) ATHEROSCLEROSIS LAB
02.2018 - 03.2020

MS - Biotechnology

New York University

BE - Biomedical Engineering

City College of New York
Shana Ravvin